Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
The states where Polio vaccine drops will be conducted includes: Bihar, Chandigarh, Delhi, Gujarat, Haryana, Jharkhand, Maharashtra, Punjab, Rajasthan, Uttarakhand, and West Bengal
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Subscribe To Our Newsletter & Stay Updated
